The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage
mSystems · 20.02.2024 · 9 (2)
DOI: 10.1128/msystems.01255-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, erschienen am 20.02.2024. Verfasst von Sweta Ghosh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Bacterial Toxins, Clostridioides difficile, Enterocolitis, Pseudomembranous, Clostridium Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIAAA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Therapy for Clostridioides difficile infections includes the use of antibiotics, immunosuppressors, and fecal microbiota transplantation. However, these treatments have several drawbacks, including the loss of colonization resistance, the promotion of autoimmune disorders, and the potential for unknown pathogens in donor samples. To date, the potential benefits of microbial metabolites in CDI-induced colitis have not been fully investigated. Here, we report for the first time that the microbial metabolite urolithin A has the potential to block toxin production from C. difficile and enhance gut barrier function to mitigate CDI-induced colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.
- UofL-Brown Cancer Center, Louisville, Kentucky, USA.
- Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA.
- Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, Kentucky, USA.
- Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky, USA.
ORCID-Profile: James Collins, Venkatakrishna Rao Jala
Förderung
- NIEHS NIH HHS
- NIAAA NIH HHS
- NIGMS NIH HHS
- HHS | National Institutes of Health
- JHFEREG
Zitieren
APA
Ghosh, S., Erickson, D., Chua, M. J., Collins, J., & Jala, V. R. (2024). The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage. mSystems, 9(2). https://doi.org/10.1128/msystems.01255-23
Vancouver
Ghosh S, Erickson D, Chua MJ, Collins J, Jala VR. The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage. mSystems. 2024;9(2). doi:10.1128/msystems.01255-23
BibTeX
@article{Ghosh2024,
author = {Ghosh, Sweta and Erickson, Daniel and Chua, Michelle J and Collins, James and Jala, Venkatakrishna Rao},
title = {The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage},
journal = {mSystems},
year = {2024},
volume = {9},
number = {2},
doi = {10.1128/msystems.01255-23}
}
EUVIMED